Lab Reference Library / ALT (Alanine Aminotransferase) Liver & Kidney

ALT (Alanine Aminotransferase)

Q: What is the optimal ALT level?

In functional medicine, optimal ALT is below 25 U/L. The conventional upper limit of normal (40 to 56 U/L depending on the laboratory) was established from population averages that include a large proportion of individuals with undiagnosed non-alcoholic fatty liver disease (NAFLD). Research from Prati and colleagues demonstrated that a more accurate upper limit of normal should be approximately 30 U/L for men and 19 U/L for women in a metabolically healthy reference population. Values above 25 U/L in otherwise healthy individuals warrant investigation for early NAFLD or metabolic liver injury.

Q: What is the AST to ALT ratio and why does it matter?

The AST/ALT ratio provides important diagnostic information about the cause of liver enzyme elevation. A ratio below 1 (ALT higher than AST) suggests non-alcoholic fatty liver disease or viral hepatitis. A ratio above 2 (AST more than twice ALT) is strongly suggestive of alcoholic liver disease. A ratio above 1 with both enzymes elevated in a cirrhotic patient suggests advanced fibrosis, as the liver loses its ability to produce ALT relatively faster than AST.

Q: Can ALT be elevated without liver disease?

Yes, though it is less common than in AST elevation. Strenuous exercise can mildly elevate ALT through muscle microinjury, though much less than AST. Celiac disease, thyroid disease (both hypothyroidism and hyperthyroidism), and adrenal insufficiency can cause mild ALT elevation. Certain medications including statins, NSAIDs, acetaminophen, and many others elevate ALT. However, ALT is significantly more liver-specific than AST, and persistent ALT elevation almost always warrants hepatic investigation.

Q: How do you lower elevated ALT?

The approach depends on the cause. For NAFLD (the most common cause): weight loss (even 5 to 10% body weight reduction produces significant ALT normalization), carbohydrate and fructose restriction, elimination of alcohol, regular aerobic exercise, and management of insulin resistance. Specific supplements with evidence for ALT reduction in NAFLD include vitamin E (800 IU daily in certain NAFLD protocols), omega-3 fatty acids, berberine, and NAC (N-acetyl cysteine). For medication-induced elevation: review and substitute where clinically feasible.

ALT · SGPT · Alanine Aminotransferase

Reference range, optimal functional medicine levels, and why ALT is the most liver-specific enzyme marker, why the conventional upper limit is set far too high for early NAFLD detection, and why even mildly elevated ALT signals significant hepatocyte injury.

Liver MarkerMost Searched

Standard Range (M)7 to 56 U/L

FM OptimalBelow 25 U/L

Standard Range (W)7 to 45 U/L

UnitsU/L

← Back to Lab Reference Library

Category: Liver & Kidney | Also known as: SGPT, Alanine Aminotransferase | Sample: Serum (fasting preferred for accuracy)

1. What This Test Measures

ALT (Alanine Aminotransferase) is an enzyme that catalyzes the transfer of an amino group from alanine to alpha-ketoglutarate in amino acid metabolism. It is found in high concentrations inside hepatocytes (liver cells), with much smaller amounts in kidney, heart, and skeletal muscle. This tissue distribution makes ALT the most liver-specific enzyme on a standard metabolic panel.

When hepatocytes are injured or destroyed, ALT leaks from damaged cells into the bloodstream. The degree of ALT elevation provides important information about the nature and severity of liver injury: the higher the elevation, the greater the amount of active hepatocellular damage occurring at that moment. However, a single mildly elevated ALT does not reveal the cause of injury, only that injury is occurring. Clinical context, pattern with other enzymes, and additional testing determine the cause.

ALT is commonly reported alongside AST, GGT, and ALP as part of a liver function panel. The pattern of these four markers together, not any single value in isolation, provides the diagnostic information needed to understand liver health.

2. Why This Test Matters

Most liver-specific enzyme marker: ALT is far more liver-specific than AST, ALP, or GGT. An isolated ALT elevation almost always indicates hepatocellular injury rather than bone, muscle, or biliary disease.
Early NAFLD detection: non-alcoholic fatty liver disease (NAFLD) is the most common cause of mild to moderate ALT elevation in developed countries, affecting an estimated 25 to 30% of adults. Because the conventional upper limit of normal is set too high (based on population averages including undiagnosed NAFLD), early hepatic steatosis is missed. Research by Prati and colleagues established that a metabolically healthy reference population has ALT values that average approximately 30 U/L in men and 19 U/L in women, significantly below the conventional cutoff.
Treatment monitoring: ALT is the primary monitoring marker for patients with known liver disease, medication-induced liver injury, or patients undergoing metabolic interventions targeting the liver. ALT trends over serial measurements are as important as any single value.
Medication safety surveillance: many medications are hepatotoxic or require liver enzyme monitoring. Statins, NSAIDs, acetaminophen, methotrexate, isoniazid, amiodarone, and many herbal supplements require ALT monitoring. Consistent ALT above 3 times the upper limit of normal on a medication typically warrants dose reduction or discontinuation.
Metabolic health signal: in the context of insulin resistance and metabolic syndrome, ALT often rises before glucose, HbA1c, or lipid markers indicate overt dysfunction. Mild ALT elevation can be an early warning of hepatic metabolic compromise years before NAFLD progresses to steatohepatitis.

3. Standard Lab Reference Range

Population	Standard Range	Units
Men (adult)	7 to 56	U/L
Women (adult)	7 to 45	U/L

Reference ranges vary by laboratory. Some labs use lower upper limits (37 U/L for men, 31 U/L for women). The key insight is that population-derived reference ranges include individuals with subclinical NAFLD and other liver pathology, systematically inflating what is considered normal.

4. Optimal Functional Medicine Range

ALT Level	Functional Interpretation
Below 20 U/L	Optimal: minimal hepatocellular stress; healthy liver metabolism
20 to 25 U/L	Low-normal: acceptable; reassess with metabolic context (insulin resistance, BMI)
25 to 40 U/L	Borderline elevated: investigate; commonly early NAFLD or metabolic liver stress
40 to 80 U/L	Mildly elevated: significant hepatocellular injury; investigate cause; intervention required
80 to 400 U/L	Moderately elevated: acute hepatocellular injury; evaluate for viral hepatitis, medications, alcohol
Above 400 U/L	Markedly elevated: severe hepatocellular injury; urgent evaluation (ischemia, toxic hepatitis, acute viral)

5. Symptoms and Associated Conditions

Mildly to moderately elevated ALT is usually entirely asymptomatic. The liver has substantial functional reserve, and ALT can be significantly elevated from early NAFLD for years without any symptoms. Symptoms, when they occur, reflect the underlying liver disease rather than ALT elevation itself:

Right upper quadrant discomfort or fullness (early NAFLD or hepatomegaly)
Fatigue and reduced energy (common in moderate to advanced liver disease)
Nausea and reduced appetite (hepatitis or advanced disease)
Jaundice (yellowing of skin and eyes) in more advanced hepatocellular injury
Abdominal swelling (ascites in cirrhosis or severe disease)
Dark urine and pale stools (biliary obstruction coexisting with hepatocellular injury)
Elevated ALT from metabolic syndrome: associated symptoms of insulin resistance, abdominal obesity, and dyslipidemia

6. What Causes Elevation

Non-alcoholic fatty liver disease (NAFLD): the most common cause of elevated ALT in developed countries; driven by insulin resistance, visceral adiposity, excess dietary carbohydrate and fructose; ALT typically ranges from 25 to 100 U/L in early NAFLD
Alcohol-induced liver injury: even moderate alcohol use elevates ALT; significantly elevated with regular heavy use; AST/ALT ratio above 2 suggests alcoholic rather than non-alcoholic etiology
Medications: statins (usually mild and transient), NSAIDs, acetaminophen (dose-dependent; hepatotoxic above 4g daily in adults, less in alcohol users), amiodarone, methotrexate, isoniazid, antifungals, and many others
Viral hepatitis: hepatitis B and C are the most common chronic causes; hepatitis A and E cause acute, often self-limiting elevation; ALT can reach 1,000 to 5,000 U/L in acute viral hepatitis
Autoimmune hepatitis: immune-mediated destruction of hepatocytes; typically presents with moderate to significant ALT elevation; confirm with ANA, ASMA, and liver biopsy
Thyroid disease: both hyperthyroidism and hypothyroidism can mildly elevate ALT through impaired hepatic enzyme clearance
Celiac disease: gluten-induced intestinal permeability allows inflammatory mediators to reach the liver; mild ALT elevation that resolves on gluten-free diet
Strenuous exercise: ALT can rise mildly after intense exercise, though far less than AST; allow 48 to 72 hours before drawing liver enzymes after intense training

7. How to Improve This Marker

Nutrition

Eliminate fructose and added sugars: the primary drivers of de novo hepatic lipogenesis and NAFLD; sugar-sweetened beverages are the most concentrated source
Reduce total carbohydrate intake: low-carbohydrate and very-low-carbohydrate diets produce the most rapid ALT normalization in NAFLD patients, often within 2 to 4 weeks
Eliminate alcohol entirely: alcohol abstinence normalizes ALT within 4 to 8 weeks in early alcoholic liver injury
Coffee (regular): the most consistent dietary intervention associated with lower ALT and reduced liver fibrosis risk; 2 to 3 cups daily; mechanism involves chlorogenic acid inhibiting hepatic lipid accumulation and NF-kB-driven inflammation
Mediterranean diet: reduces hepatic inflammation and steatosis beyond weight loss alone

Lifestyle

Weight loss: the most impactful intervention for NAFLD-related ALT elevation; even 5 to 7% body weight loss produces significant ALT normalization; 10% weight loss is associated with histological improvement in liver steatosis
Aerobic exercise: reduces hepatic fat content independent of weight loss; 150 minutes per week of moderate-intensity aerobic exercise consistently lowers liver fat and ALT
Resistance training: adds independent benefit through improved insulin sensitivity and reduced visceral adiposity
Avoid medications not strictly necessary: review all medications, supplements, and herbal products for hepatotoxic potential; discuss alternatives with prescribing physician
Time the blood draw correctly: avoid drawing liver enzymes within 48 to 72 hours of intense exercise

Targeted Support

Vitamin E (800 IU d-alpha-tocopherol daily): the most evidence-based supplement for NAFLD-associated ALT reduction; significantly reduces ALT and hepatic inflammation in non-diabetic NAFLD patients in the PIVENS trial; use with caution above 400 IU daily in patients with cardiovascular disease history
Omega-3 fatty acids (2 to 4g EPA and DHA daily): reduce hepatic lipid accumulation, triglycerides, and inflammation; consistently lower ALT in NAFLD
Berberine (500mg three times daily): improves insulin sensitivity and reduces hepatic lipid accumulation; clinical trials demonstrate significant ALT reduction in NAFLD patients
NAC (N-acetylcysteine): glutathione precursor; supports hepatic antioxidant capacity; reduces ALT in acetaminophen toxicity (the FDA-approved treatment) and in other oxidative liver injury
Milk thistle (silymarin): hepatoprotective; reduces ALT in drug-induced and alcoholic liver injury; 140mg silymarin three times daily

The Complete Liver Enzyme Panel: Pattern Interpretation

No single liver enzyme is interpreted in isolation. The pattern of ALT, AST, GGT, and ALP together determines the clinical direction:

Pattern	ALT	AST	GGT	ALP	Most Likely Cause
Hepatocellular (NAFLD)	High	Mildly high	Mildly high	Normal	Non-alcoholic fatty liver disease; metabolic liver injury
Alcoholic hepatitis	Elevated	Greater than 2x ALT	Markedly high	Normal to mild	Alcohol; AST/ALT ratio above 2 is hallmark
Biliary obstruction	Mildly elevated	Mildly elevated	High	Markedly high	Choledocholithiasis, cholangiocarcinoma, pancreatic mass
PBC / PSC	Mildly elevated	Mildly elevated	High	Markedly high	Autoimmune biliary disease; check AMA (PBC) or MRCP (PSC)
Bone source	Normal	Normal or mild	Normal	Elevated	Paget's disease, bone metastases, healing fracture, adolescent growth
Viral hepatitis (acute)	Very high	High	Elevated	Mildly elevated	Hepatitis A, B, C, E; ALT typically higher than AST
Ischemic hepatitis	Markedly elevated	Markedly elevated	Elevated	Mildly elevated	Congestive heart failure; shock; hepatic artery occlusion

9. Related Lab Tests

ASTLiver Enzyme Pattern Partner

→

GGTAlcohol and Oxidative Stress Marker

→

ALPBiliary Pattern Marker

→

Fasting InsulinInsulin Resistance Drives NAFLD

→

TG/HDL RatioMetabolic Liver Disease Context

→

FerritinElevated in NAFLD and Iron Overload

→

10. When Testing Is Recommended

Standard annual metabolic panel; ALT should be evaluated alongside AST, GGT, and ALP for a complete liver enzyme pattern
Patients with insulin resistance, metabolic syndrome, obesity, or type 2 diabetes; NAFLD is present in 50 to 75% of this population
Alcohol use; even moderate drinking elevates ALT and warrants periodic monitoring
Patients on statin therapy, methotrexate, isoniazid, amiodarone, or other hepatotoxic medications; baseline and periodic monitoring required
Suspected viral hepatitis (hepatitis B or C exposure, injection drug use history)
Unexplained fatigue or right upper quadrant discomfort
Monitoring response to NAFLD-targeted interventions (weight loss, dietary changes, supplements)
Any comprehensive functional medicine metabolic or longevity panel

11. Clinical Perspective

Clinical Perspective

The single most common finding I see on routine bloodwork that goes unaddressed is an ALT between 35 and 55 U/L that the lab report marks normal. The patient is told their liver is fine. But in a metabolically healthy person, ALT should be below 25, ideally below 20. An ALT of 48 in someone with a waist circumference of 41 inches, a TG/HDL ratio of 4, and a fasting insulin of 15 is almost certainly early non-alcoholic fatty liver disease. It is not normal. It is a window into what is happening in the liver before imaging can detect it, and it is exactly the right moment to intervene with dietary carbohydrate restriction, weight loss, and berberine. The liver responds very quickly when we get the metabolic conditions right. I have seen ALT go from 58 to 19 in 12 weeks on the right protocol. That is a liver healing in real time.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

12. Frequently Asked Questions

What is the optimal ALT level?

In functional medicine, optimal ALT is below 25 U/L, and ideally below 20 U/L. The conventional upper limit (40 to 56 U/L) is derived from population averages that include individuals with undiagnosed NAFLD and other subclinical liver disease. Research by Prati and colleagues established that a metabolically healthy reference population has ALT values averaging approximately 30 U/L for men and 19 U/L for women, significantly below the conventional cutoff.

What does elevated ALT mean?

Elevated ALT indicates hepatocyte (liver cell) injury or death, releasing the intracellular enzyme into the bloodstream. The most common cause of mildly to moderately elevated ALT (25 to 80 U/L) is non-alcoholic fatty liver disease (NAFLD) driven by insulin resistance and excess dietary carbohydrate and fructose. Higher elevations suggest viral hepatitis, alcohol, medications, or autoimmune hepatitis. Very high ALT (above 1,000 U/L) indicates severe hepatocellular injury from ischemia, toxic hepatitis, or acute viral hepatitis.

What is the AST to ALT ratio and why does it matter?

The AST/ALT ratio distinguishes causes of liver enzyme elevation. A ratio below 1 (ALT higher than AST) is typical of NAFLD and viral hepatitis. A ratio above 2 (AST more than twice ALT) is strongly associated with alcoholic liver disease. A ratio above 1 in a cirrhotic patient suggests advanced fibrosis. This ratio is one of the most important patterns in the complete liver enzyme panel.

How do you lower elevated ALT?

For NAFLD (the most common cause): eliminate added sugars and fructose, restrict total carbohydrate intake, lose 5 to 10% body weight, eliminate alcohol, exercise regularly, and manage insulin resistance. Evidence-based supplements include omega-3 fatty acids (2 to 4g daily), vitamin E (800 IU for non-diabetic NAFLD), berberine, and milk thistle. ALT typically responds within 4 to 12 weeks of consistent dietary intervention.

Can ALT be elevated without liver disease?

Mildly elevated ALT can occur from strenuous exercise (allow 48 to 72 hours after intense training before drawing liver enzymes), celiac disease, thyroid disease, adrenal insufficiency, and certain medications. However, ALT is significantly more liver-specific than AST, and persistent ALT elevation above 25 U/L in a non-exercising adult almost always warrants investigation for hepatic causes.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Your ALT is normal on the report. Your liver may disagree.

An ALT of 45 U/L in a person with insulin resistance and metabolic syndrome is not a liver in good health. Schedule a consultation for a complete liver and metabolic panel evaluation.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.